Piper Sandler analyst David Westenberg raised the firm’s price target on Elanco (ELAN) to $18 from $12 following quarterly results. The firm keeps a Neutral rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELAN:
- Elanco price target raised to $19 from $18 at UBS
- Elanco Animal Health: Hold Rating Amid Strong Growth and Pipeline Uncertainties
- Elanco Animal Health Reports Strong Q2 2025 Results
- Morning Movers: Apple adds to yesterday’s gains, Trump calls out Intel CEO
- Elanco Animal Health: Strong Performance and Growth Potential Drive Buy Rating